Long-term drug survival of biological agents in patients with rheumatoid arthritis in clinical practice-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Long-term drug survival of biological agents in patients with rheumatoid arthritis in clinical practice

Published:2016-04-26 Issue:6 Volume:45 Page:456-460
ISSN:0300-9742
Container-title:Scandinavian Journal of Rheumatology
language:en
Short-container-title:Scandinavian Journal of Rheumatology

Author:

Leon L¹²,Rodriguez-Rodriguez L¹,Rosales Z³,Gomez A³,Lamas JR¹,Pato E³,Jover JA³⁴,Abasolo L¹

Affiliation:

1. Health Research Institute, San Carlos Clinical Hospital (IDISSC), Madrid, Spain

2. Camilo Jose Cela University, Madrid, Spain

3. Department of Rheumatology, San Carlos Clinical Hospital (IDISSC), Madrid, Spain

4. Department of Medicine, Complutense University, Madrid, Spain

Funder

Pfizer Foundation

Publisher

Informa UK Limited

Subject

Immunology,General Medicine,Immunology and Allergy,Rheumatology

Link

https://www.tandfonline.com/doi/pdf/10.3109/03009742.2016.1141979

Reference15 articles.

1. The efficacy of anti-TNF in rheumatoid arthritis, a comparison between randomised controlled trials and clinical practice

2. Long-Term Drug Survival of TNF Inhibitor Therapy in RA Patients: A Systematic Review of European National Drug Registers

3. Changing Patterns of Tumor Necrosis Factor Inhibitor Use in 9074 Patients with Rheumatoid Arthritis

4. Retention rates of adalimumab, etanercept and infliximab as first and second-line biotherapy in patients with rheumatoid arthritis in daily practice

5. TNF-α Antagonist Survival Rate in a Cohort of Rheumatoid Arthritis Patients Observed under Conditions of Standard Clinical Practice

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reasons for multiple biologic and targeted synthetic DMARD switching and characteristics of treatment refractory rheumatoid arthritis;Seminars in Arthritis and Rheumatism;2024-06

2. Distinct long-term disease activity trajectories differentiate early on treatment with etanercept in both rheumatoid arthritis and spondylarthritis patients: a prospective cohort study;Rheumatology International;2023-10-10

3. First multi-center retrospective study assessed the compliance with and persistence of biological therapies in Bulgarian population with rheumatoid arthritis;Rheumatology International;2023-09-30

4. Real-World Data of Adherence and Drug Survival of Biologics in Treatment-Naïve and Treatment-experienced Adult Patients with Rheumatoid Arthritis;Advances in Therapy;2023-08-11

5. Reasons for Multiple Biologic and Targeted Synthetic Dmard Switching and Characteristics of Treatment Refractory Rheumatoid Arthritis;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3